Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

HYDROcodone

HYDROcodone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Zohydro ER CAPSULE, EXTENDED RELEASE, ORAL 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg    
Vantrela ER TABLET, EXTENDED RELEASE, ORAL 15 mg, 30 mg, 45 mg, 60 mg, 90 mg    
Hysingla ER TABLET, EXTENDED RELEASE, ORAL 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

HYDROcodone (Hysingla ER)

  • 20 mg ER tablet Daily
  • 30 mg ER tablet Daily
  • 40 mg ER tablet Daily
  • 60 mg ER tablet Daily
  • 80 mg ER tablet Daily
  • 100 mg ER tablet Daily
  • 120 mg ER tablet Daily

morphine (MS Contin)

  • 15 mg/12 hours ER tablet BID
  • 15 mg/12 hours ER tablet BID
  • 15 mg/12 hours ER tablet q8h
  • 30 mg/12 hours ER tablet BID
  • 30 mg/12 hours ER tablet q8h
  • 60 mg/12 hours ER tablet BID
  • 60 mg/12 hours ER tablet BID

HYDROcodone (Vantrela ER)

  • 15 mg ER tablet BID
  • 30 mg ER tablet BID
  • 45 mg ER tablet BID
  • 60 mg ER tablet BID
  • 90 mg ER tablet BID

morphine (MS Contin)

  • 15 mg/12 hr ER tablet BID
  • 30 mg/12 hr ER tablet BID
  • 30 mg/12 hr ER tablet Q8 hrs
  • 60 mg/12 hr ER tablet BID
  • 60 mg/12 hr ER tablet Q8 hrs

HYDROcodone (Zohydro ER)

  • 10 mg ER capsule BID
  • 15 mg ER capsule BID
  • 20 mg ER capsule BID
  • 30 mg ER capsule BID
  • 40 mg ER capsule BID
  • 50 mg ER capsule BID

morphine (MS Contin)

  • 15 mg/12 hours ER tablet BID
  • 15 mg/12 hours ER tablet BID
  • 15 mg/12 hours ER tablet q8h
  • 30 mg/12 hours ER tablet BID
  • 30 mg/12 hours ER tablet q8h
  • 60 mg/12 hours ER tablet BID

Hysingla ER medication guide

Vantrela ER medication guide

Zohydro ER medication guide

Vantrela ER is non-formulary with an automatic interchange to MS Contin at an equivalent daily dose -- either BID or TID.

Reviewed: July 22, 2014 (ZOHYDRO ER), and 24 February 2015 (Hysingla ER), and 23 May 2017 (Vantrela ER)

REMS (Hysingla ER, Zohydro ER): View FDA REMS Info

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved